Project Grant R43MH143566
- Federal Grant Award Summary Bend Health, Inc. received a $291,491 Project Grant from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242), effective August 1, 2025, through July 31, 2028. The award funds the development and feasibility testing of an enhanced digital mental health intervention designed to address self-injurious thoughts or behaviors (SITBs) among adolescents. Specifically, Bend Health will expand its existing Remote Rapid...
- The National Institute of Mental Health awarded the University of Oregon $745,000 on July 1, 2026, under the Mental Health Research Grants program (CFDA 93.242) to conduct a hybrid implementation-effectiveness trial examining the feasibility and potential effectiveness of implementing Collaborative Assessment and Management of Suicidality for Teens (CAMS-4TEENS, or C4T) in Oregon school-based health centers. The project will deploy C4T, an evidence-based suicide intervention adapted from an...
- The National Institute of Mental Health awarded Northwestern University $188,499 under the Mental Health Research Grants program (CFDA 93.242) on July 24, 2026, to adapt digital single-session interventions for delivery by lay providers in rural high schools. The project focuses on addressing barriers to mental health care for adolescents with depression in rural communities, where internalizing problems are more prevalent yet mental health providers and treatment options are scarce. The...
- The National Institute of Mental Health awarded $1,415,720 to Deliberate Solutions Inc. on August 5, 2026, under the Mental Health Research Grants program (CFDA 93.242) to advance AI-CLINICAL OUTCOME ASSESSMENT (AI-COA) for Depression toward regulatory qualification and commercial readiness as a drug development tool. The project funds technical development and clinical validation of AI-COA, a multimodal artificial intelligence tool designed to provide objective, standardized assessment of...
- The National Institute of Mental Health awarded Oregon Health & Science University $164,190 on December 19, 2025, under the Mental Health Research Grants program (CFDA 93.242) to fund a longitudinal study examining internalizing symptoms in adolescence through the lens of negative life events, emotion regulation dysfunction, and neurobiological mechanisms, with performance through July 31, 2029, at the Portland, Oregon campus. The research addresses the elevated prevalence and high...
- The National Institute of Mental Health awarded the University of Colorado $430,163 on March 15, 2026, under the Mental Health Research Grants program (CFDA 93.242) to validate and translate a smartphone-based intervention monitoring approach (SBIM) for adolescents with mood disorders. The project develops a low-burden monitoring strategy to improve adherence to inter-session behavioral and mood tracking in adolescent mental health interventions. Study participants (N=33, ages 13–19 years)...
- The National Institute of Mental Health awarded the University of Oregon $159,560 on January 1, 2027, under the Mental Health Research Grants program (CFDA 93.242) to conduct a study examining the bidirectional dynamics of daily behavior and mood associated with adolescent non-suicidal self-injury using passive mobile sensing. The research leverages passive smartphone data collection, including GPS technology and the Effortless Assessment of Risk States (EARS) platform, to observe associations...
- The National Institute of Mental Health awarded the University of Oregon $100,138 on February 1, 2027, to conduct longitudinal research characterizing the links between affective development and the emergence of depression symptoms in adolescent girls under the Mental Health Research Grants program (CFDA 93.242). The project analyzes six waves of data from the Longitudinal Transitions in Adolescent Girls Study spanning participants' second decade of life (N=174; age 10–13 at baseline). The...
- The National Institute of Mental Health awarded The Trustees of Columbia University in the City of New York $180,360 on May 11, 2026, to design and test a brief single-session web-based intervention for adolescents with depression, adapting interpersonal psychotherapy for adolescents (IPT-A) into a digital format deployable through Mental Health America's online depression screening platform. The project runs through April 30, 2031, with performance in New York. Work proceeds across three...
- The National Institute of Mental Health awarded Miresource, Inc. $1.744 million on September 12, 2025, under the Mental Health Research Grants program (CFDA 93.242) to develop a longitudinal mental health monitoring platform that generates personalized care guides and treatment referrals. Miresource will integrate software solutions, curate mental health content, and employ artificial intelligence to create personalized guides and automate triage and referral recommendations. The project aims to...
The National Institute of Mental Health awarded Oregon Research Behavioral Intervention Strategies, Inc. (doing business as Influents Innovations) $314,362 under the Mental Health Research Grants program (CFDA 93.242) on September 1, 2026, to develop a digital evidence-based app for providers and teens addressing depression and subclinical depressive symptoms in youth. The project addresses the gap between the prevalence of depressive symptoms in adolescents and access to treatment. Cognitive behavioral therapy (CBT) has proven effective for mild to moderate depression, but in-person psychosocial therapy faces barriers of cost, resource availability, and trained professional capacity; 59.4 percent of adolescents reporting a major depressive episode in the prior year did not receive treatment. The recipient will develop a scalable, youth-centered digital intervention that spans subclinical symptoms and clinical depression, integrating personalized content, brief skill-focused sessions, and engagement guidance to complement or substitute for in-person therapy. The award runs from September 1, 2026 through August 31, 2027, with place of performance in Springfield, Oregon. This is a Phase I project grant, an assistance type common to NIMH's Small Business Innovation Research (SBIR) and exploratory grant programs. The recipient is a for-profit technology company specializing in digital behavioral health solutions, with prior NIMH project grant experience in digital cognitive-behavioral therapy and other mental health technology platforms.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $314.4k | 8/21/26 |